The metabolic changes associated with fat breakdown may temporarily increase uric acid levels, whilst dietary modifications might inadvertently include trigger foods or inadequate hydration
In particular, DAS and its metabolites have been found to inhibit CYP2E1 activity in vitro (56, 57) and when administered orally at high doses to animals (58, 59)
Despite the health benefits of weight-loss interventions like nutritional counseling, bariatric surgery, and medications like GLP-1 receptor agonists, utilization of obesity-related healthcare remains extremely low, especially by populations that are most affected by obesity
Retatrutide is currently an investigational drug that is not yet FDA-approved for weight loss
Weintraub: Weve designed it for busy clinicians with three, 20-minute microlearning modules